{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T14:56:16Z","timestamp":1774018576474,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJID Regions"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ijregi.2025.100708","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T17:00:54Z","timestamp":1752858054000},"page":"100708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Outcomes and microbiological patterns of bacteremia in chemotherapy-related febrile neutropenia at a tertiary facility in Kenya"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5643-2943","authenticated-orcid":false,"given":"Abhijit","family":"Ghose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmit","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Mwirigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Makasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Riunga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijregi.2025.100708_bib0001","doi-asserted-by":"crossref","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","article-title":"Management of febrile neutropaenia: ESMO Clinical Practice Guidelines","volume":"27","author":"Klastersky","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijregi.2025.100708_bib0002","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0002-9343(80)90472-6","article-title":"Dose: a critical factor in cancer chemotherapy","volume":"69","author":"Frei","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.ijregi.2025.100708_bib0003","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.eimc.2019.01.013","volume":"38","author":"Gudiol","year":"2020","journal-title":"Enferm Infecc Microbiol Clin (Engl)"},{"key":"10.1016\/j.ijregi.2025.100708_bib0004","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1469-0691.2012.03879.x","article-title":"Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients","volume":"19","author":"Gudiol","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijregi.2025.100708_bib0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fcimb.2015.00011","volume":"5","author":"Moghnieh","year":"2015","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijregi.2025.100708_bib0006","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10096-013-1819-7","article-title":"Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance","volume":"32","author":"Montassier","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijregi.2025.100708_bib0007","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1086\/374339","article-title":"Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States","volume":"36","author":"Wisplinghoff","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2025.100708_bib0008","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.ijregi.2025.100708_bib0009","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2025.100708_bib0010","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.21847","article-title":"Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients","volume":"106","author":"Kuderer","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijregi.2025.100708_bib0011","article-title":"Fever and neutropenia outcomes and areas for intervention: a report from SUCCOUR - Supportive Care for Children with Cancer in Africa","volume":"68","author":"Israels","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijregi.2025.100708_bib0012","first-page":"43","article-title":"Factors associated with treatment outcome of pediatric cancerpatients admitted with febrile neutropenia in Tikuranbessa specialized teaching hospital, Addis Ababa, Ethiopia","volume":"55","author":"Assefa","year":"2017","journal-title":"Ethiop Med J"},{"key":"10.1016\/j.ijregi.2025.100708_bib0013","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s13104-019-4520-9","article-title":"Bacteremia in febrile cancer patients in Uganda","volume":"12","author":"Lubwama","year":"2019","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ijregi.2025.100708_bib0014","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/00365540510038497","article-title":"A multi-centre prospective study of febrile neutropenia in Norway: microbiological findings and antimicrobial susceptibility","volume":"37","author":"Sigurdardottir","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijregi.2025.100708_bib0015","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/1078155216687150","article-title":"Association of time to antibiotics and clinical outcomes in adult hematologic malignancy patients with febrile neutropenia","volume":"23","author":"Butts","year":"2017","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.ijregi.2025.100708_bib0016","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/cncr.20983","article-title":"Linde-Zwirble WT. Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy","volume":"103","author":"Caggiano","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ijregi.2025.100708_bib0017","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1016\/j.cllc.2017.10.013","article-title":"Analysis of factors associated with in-hospital mortality in lung cancer chemotherapy patients with neutropenia","volume":"19","author":"Cupp","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijregi.2025.100708_bib0018","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3111\/13696998.2013.782034","article-title":"A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia","volume":"16","author":"Dulisse","year":"2013","journal-title":"J Med Econ"},{"key":"10.1016\/j.ijregi.2025.100708_bib0019","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1001\/archinte.1988.00380120031007","article-title":"The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation","volume":"148","author":"Talcott","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijregi.2025.100708_bib0020","first-page":"303","article-title":"Management of febrile neutropenia in patients receiving chemotherapy for solid tumors: a retrospective study of twenty cases from the radiotherapy centre, Accra, Ghana","volume":"29","author":"Vanderpuye","year":"2010","journal-title":"West Afr J Med"},{"key":"10.1016\/j.ijregi.2025.100708_bib0021","first-page":"720","article-title":"Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital","volume":"53","author":"Poon","year":"2012","journal-title":"Singapore Med J"},{"key":"10.1016\/j.ijregi.2025.100708_bib0022","first-page":"1447","article-title":"Direct costs associated with febrile neutropenia in inpatients with hematological diseases in Singapore","volume":"22","author":"Zhou","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijregi.2025.100708_bib0023","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/oncolo\/oyac074","article-title":"Chemotherapy-induced neutropenia and febrile neutropenia in the US: A beast of burden that needs to be tamed?","volume":"27","author":"Boccia","year":"2022","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.ijregi.2025.100708_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108969","article-title":"Factors Associated with Hospital Length of Stay among Cancer Patients with Febrile Neutropenia","volume":"9","author":"Rosa","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ijregi.2025.100708_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2007.06.012","article-title":"Bacteraemia in febrile neutropenic cancer patients","volume":"30","author":"Klastersky","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijregi.2025.100708_bib0025","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0959-8049(94)90412-X","article-title":"Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC)","volume":"30A","author":"Viscoli","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijregi.2025.100708_bib0026","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00277-012-1424-3","article-title":"P. aeruginosa bloodstream infections among hematological patients: an old or new question?","volume":"91","author":"Cattaneo","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijregi.2025.100708_bib0027","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/AAC.38.4.681","article-title":"Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center","volume":"38","author":"Kern","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijregi.2025.100708_bib0028","first-page":"2371","article-title":"Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia","volume":"20","author":"Kang","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijregi.2025.100708_bib0029","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1007\/s12032-011-9858-3","article-title":"Profile of infections and outcome in high-risk febrile neutropenia: experience from a tertiary care cancer center in India","volume":"29","author":"Ghosh","year":"2012","journal-title":"Med Oncol"}],"container-title":["IJID Regions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707625001432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707625001432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:22:05Z","timestamp":1770898925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772707625001432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":30,"alternative-id":["S2772707625001432"],"URL":"https:\/\/doi.org\/10.1016\/j.ijregi.2025.100708","relation":{},"ISSN":["2772-7076"],"issn-type":[{"value":"2772-7076","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes and microbiological patterns of bacteremia in chemotherapy-related febrile neutropenia at a tertiary facility in Kenya","name":"articletitle","label":"Article Title"},{"value":"IJID Regions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijregi.2025.100708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"100708"}}